NeuroSearch (Huntexil) Overview

  • Status
  • Acquired/​Merged
  • Latest Deal Type
  • Asset Purch.
  • Financing Rounds
  • 1

NeuroSearch (Huntexil) General Information

Description

Neuro control drug to treat patients from Huntington disease. The drug is used as a symptomatic agent, and enables the patients to get rid of the irregularities of their hand movement, balance and gait disturbances caused due to the Huntington disease.

Contact Information

Ownership Status
Acquired/Merged
Financing Status
Corporate Backed or Acquired
Primary Industry
Buildings and Property
Other Industries
Drug Discovery
Primary Office
  • Strandvejen 60
  • 2900 Hellerup
  • Denmark
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

NeuroSearch (Huntexil) Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore NeuroSearch (Huntexil)‘s full profile, request access.

Request a free trial

NeuroSearch (Huntexil) Former Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore NeuroSearch (Huntexil)‘s full profile, request access.

Request a free trial